Axsome to Present Results of SHARP Study at Psych Congress :

Axsome is set to present new data on Sunosi (solriamfetol) in patients with excessive daytime sleepiness (EDS) due to narcolepsy and OSA.

Related Keywords

Germany , David Gozal , Johannes Gutenberg , Craig Chepke , Hans Van Dongen , Washington State University , Axsome Therapeutics Inc , Medicine Center , Psych Congress , University Of Missouri , Cecilia Brain , Cognitive Function , Obstructive Sleep Apnea , Washington State , Solriamfetol Improves Cognitive Performance , Preclinical Models , Sleep Apnea , Randomized Placebo Controlled Study , Sleep Apnea Participants , Excessive Sleepiness , Effect Sizes , Numbers Needed , Follow Up Experience , Patients With , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University ,